Publicaciones científicas

¿Necesita concretar más?
/cun/investigacion/publicaciones-cientificas/areaMain/02

  • Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplantation in multiple myeloma

    Rosiñol L (1), Oriol A (2), Rios R (3), Sureda A (4), Blanchard MJ (5), Hernández MT (6), Martínez-Martínez R (7), Moraleda JM (8), Jarque I (9), Bargay J (10), Gironella M (11), de Arriba F (12), Palomera L (13), Gonzalez-Montes Y (14), Marti J (15), Krsnik I (16), Arguiñano JM (17), Gonzalez ME (18), Gonzalez AP (19), Casado LF (20), Lopez-Anglada L (21), Paiva B (22), Mateos MV (23), San Miguel J (24), Lahuerta JJ (25), Bladé J (26).

    (1) Hospital Clínic, Institut d'investigacions Biomèdiques August Pi i Sunyer, Spain
    (2) Clinical Hematology, ICO - Hosp Germans Trias i Pujol, Spain.
    (3) Hospital Universitario Virgen de las Nieves, Spain.
    (4) Haematology, Institut Català d'Oncologia, Spain.
    (5) Hematology, Hospital Ramon y Cajal, Spain.
    (6) Hematology, Hospital Universitario de Canaria, Spain.
    (7) Hospital Clínico San Carlos.
    (8) Hematology., Hospital Universitario Virgen de la Arrixaca. University of Murcia, Spain.
    (9) Hematology, Hospital Universitari i Politècnic La Fe, Spain.
    (10) Hospital Universitario Son Llàtzer, Spain.
    (11) Hospital Universitario Vall d'Hebron, Spain.
    (12) Hematologia y Oncología Médica, Hospital General Universitario Morales Meseguer, Spain.
    (13) Hematology, Hospital Clínico, Spain.
    (14) hematologia ICO, hospital josep trueta, Spain.
    (15) Hospital la Mutua de Terrassa, Spain.
    (16) Hematology, Hospital Universitario Puerta de Hierro, Spain.
    (17) Complejo Hospitalario de Navarra, Spain.
    (18) Hematology, Hospital Cabueñes, Spain.
    (19) Hospital Universitario Central de Asturias, Spain.
    (20) Hematology, Hospital Virgen de la Salud, Spain.
    (21) Hospital Universitario, Spain.
    (22) Hematology, Clinica Universidad de Navarra, Spain.
    (23) Department of Hematology, University Hospital of Salamanca/IBSAL/Cancer Research Center, Spain.
    (24) Clinica Universidad de Navarra, Universidad de Navarra, Spain.
    (25) Hematology, Hospital Universitario 12 de Octubre, Spain.
    (26) Hospital Clínic Universitari, IDIBAPS, Barcelona, Spain.

    Blood 04 de SEPTIEMBRE de 2019

  • B Cell Adaptive Immune Profile in Emphysema-Predominant COPD

    Sullivan JL (1), Bagevalu B (1), Glass C (2), Sholl L (3), Kraft M (4), Martinez FD (5), Bastarrika G (6), de-Torres JP (7), San José Estépar R (8), Guerra S (9), Polverino F (10).

    (1) Asthma and Airway Disease Research Center, University of Arizona , Medicine, Tucson, Arizona, United States.
    (2) Duke University School of Medicine, 12277, Durham, North Carolina, United States.
    (3) Brigham and Women's Hospital, Boston, Massachusetts, United States.
    (4) University of Arizona College of Medicine, Internal Medicine, Tucson, Arizona, United States.
    (5) University of Arizona HSC, Tucson, Arizona, United States.
    (6) Clinica Universidad de Navarra, Radiology Department., Pamplona, Navarra, Spain.
    (7) Clinica Universitaria de Navarra, 16755, Pulmonary, Pamplona, Spain.
    (8) Brigham and Women's Hospital, Radiology, Boston, Massachusetts, United States.
    (9) University of Arizona, Tucson, United States.
    (10) Asthma and Airway Disease Research Center, University of Arizona , Medicine, Tucson, Arizona, United States

    American Journal of Respiratory and Critical Care Medicine 26 de JULIO de 2019

  • Burkitt-like lymphoma with 11q aberration

    Gonzalez-Farre B (1), Ramis-Zaldivar JE (2), Salmeron-Villalobos J (2), Balagué O (1), Celis V (3), Verdu-Amoros J (4), Nadeu F (2), Sábado C (5), Ferrández A (6), Garrido M (7), García-Bragado F (8), de la Maya MD (9), Vagace JM (9), Panizo CM (10), Astigarraga I (11), Andrés M (12), Jaffe ES (13), Campo E (14), Salaverria I (15).

    (1) Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
    (2) Institut Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
    (3) Pediatric Oncology Department, Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain.
    (4) Pediatric Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
    (5) Pediatric Oncology Department, Hospital Universitari Vall Hebron, Barcelona, Spain.
    (6) Pathology Department, Hospital Clínico de Valencia, Valencia, Spain.
    (7) Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
    (8) Pathology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
    (9) Pediatric Hematology Department, Hospital Materno Infantil de Badajoz, Badajoz, Spain.
    (10) Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain.
    (11) Pediatrics Department, Hospital Universitario Cruces, Barakaldo, Spain.
    (12) Pediatric Oncology Department, Hospital La Fe, Valencia, Spain.
    (13) Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD.
    (14) Hematopathology Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
    (15) Institut Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

    Haematologica 07 de FEBRERO de 2019

  • Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria

    Schoepke N (1), Asero R (2), Ellrich A (1), Ferrer M (3), Gimenez-Arnau A (4), E H Grattan C (5), Jakob T (6,7), Konstantinou GN (8), Raap U (9), Skov PS (10,11), Staubach P (12), Kromminga A (13,14), Zhang K (15), Bindslev-Jensen C (16), Daschner A (17), Kinaciyan T (18), Knol EF (19), Makris M (20), Marrouche N 21, Schmid-Grendelmeier P (22,23), Sussman G (24), Toubi E (25), Church MK (1), Maurer M (1).

    (1) Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
    (2) Department of Allergology, Clinica San Carlo, Paderno Dugnano (MI), Italy.
    (3) Department of Allergy and Clinical Immunology, Clinica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Pamplona, Spain.
    (4) Department of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma Barcelona, Barcelona, Spain.
    (5 )Guy's Hospital, London, UK.
    (6) Department of Dermatology and Allergology, University Medical Center Giessen and Marburg, Justus-Liebig University Gießen, Gießen, Germany.
    (7) Allergy Research Group, Medical Center, University of Freiburg, Freiburg, Germany.
    (8) Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Thessaloniki, Greece.
    (9) Department of Human Medicine and Health Sciences, University Clinic of Dermatology and Allergy, University of Oldenburg, Oldenburg, Germany.
    (10) RefLab ApS, Copenhagen, Denmark.
    (11) Odense Research Center of Anaphylaxis, ORCA, Odense, Denmark.
    (12) Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
    (13) Bioagilytix Europe GmbH, Hamburg, Germany.
    (14) Institute of Immunology, University of Kiel, Kiel, Germany.
    (15 )Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
    (16) Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
    (17) Servicio de Alergia, Instituto de Investigación Sanitaria (IIS)- Hospital Universitario de la Princesa, Madrid, Spain.
    (18) Department of Dermatology, Medical University of Vienna, Vienna, Austria.
    (19) Departments of Immunology and Dermatology/Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
    (20) Allergy Unit, 2nd Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, Attikon" University Hospital, Athens, Greece.
    (21) Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.
    (22) Allergy Unit, Department of Dermatology, University Hospital, Zürich, Switzerland.
    (23) Christine Kühne Center for Allergy Research and Education CK-CARE, Davos, Switzerland.
    (24) Division of Allergy and Clinical Immunology, University of Toronto, Toronto, Ontario, Canada.
    (25) Faculty of Medicine, Bnai-Zion Medical Center, Technion, Haifa, Israel.

    Allergy 22 de ENERO de 2019

  • Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes

    Volders JH (1), Negenborn VL (2), Spronk PE (3), Krekel NMA (2), Schoonmade LJ (4), Meijer S (1), Rubio IT (5), van den Tol MP (6).

    (1) Department of Surgical Oncology, VU University Medical Center, De Boelelaan 1117, Room 7F-020, 1081 HV, Amsterdam, The Netherlands.
    (2) Department of Plastic, Reconstructive and Hand Surgery, VU University Medical Center, Amsterdam, The Netherlands.
    (3) Dutch Institute for Clinical Auditing, Leiden, The Netherlands.
    (4) Medical Library, VU University Amsterdam, Amsterdam, The Netherlands.
    (5) Breast Cancer Surgical Unit, Breast Cancer Center, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
    (6) Department of Surgical Oncology, VU University Medical Center, De Boelelaan 1117, Room 7F-020, 1081 HV, Amsterdam, The Netherlands.

    Breast Cancer Research Treatment 06 de DICIEMBRE de 2017

Anterior 1 2 3 ... 21 Siguiente

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra